Hydralazine-Associated Vasculitis and Pulmonary Hemorrhage

Cureus. 2023 Apr 9;15(4):e37332. doi: 10.7759/cureus.37332. eCollection 2023 Apr.

Abstract

Hydralazine is a potent vasodilating medication used as adjunctive therapy for the treatment of hypertension. Rarely, hydralazine may cause the development of antineutrophil cytoplasmic antibody vasculitis with the pulmonary-renal syndrome. We are presenting a case of hydralazine-associated vasculitis and pulmonary hemorrhage.

Keywords: anca; anca-associated vasculitis; hydralazine-induced vasculitis; hypertension; pulmonary hemorrhage; vasculitis.

Publication types

  • Case Reports